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Introduction
• Early mammalian embryonic development in both sexes
involves the formation of two pairs of urogenital ducts
termed the Wolffian (WD) and Müllerian ducts (MD).
• It is known that the two MD will fuse to form the uterine
corpus, and it is thought that the degree of fusion leads
to the variation of uterus morphology [1].
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We have confirmed that the
MD fusion window is
between E13-E14.5. We
have determined the lengths
of the developing Müllerian
ducts and the physical
relationships between the
two ducts before, during and
after fusion. We have
defined the regions of
interest of the fusing MD for
single cell transcriptome
analysis. These studies
should lead to a cell and
molecular understanding of
MD fusion for uterine
morphogenesis.
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Figure 2: Representative images of the MD ducts.
Scale bar, 500 μm.
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Figure 1: Different uterine morphology
(A) Simplex uterus in human (B) Bicornuate uterus in mice

• Several observed uterine variations are the result of MD
fusion failure [2]. However, there is a gap in our
knowledge with regards to the MD fusion with little
research investigating this process.
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• Here, we choose mice as our research organism and
focus on (1) characterizing the timing, position, and
morphological landmarks during the fusion process and
(2) determining the region of interest (ROI) for single cell
RNA sequencing.

Figure 3: The MD growth and fusion model. Oviduct-region MD don’t
proliferate. Uterine-region MD proliferate at different rates over time.
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• Determining ROI for single cell RNA sequencing:
Dissection at E13.5
and E14.5
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SD (µm)

Total vertical length

865

61

Green

1262

101

Red

307

95

173, 123, 107

16, 16, 25

Total vertical length

1255

237

Green

1565

358

Dark Red

828

271

Purple

243

35

Total vertical length

1278

253

Green

1297

191

Dark Red

1041

237

Purple

466

34

Table 1: Measured length of different MD features
MESONEPHROS

Varying
dissection
region
Single-cell
suspension

Average (µm)

Distance between red features
(top, mid, bottom)

• Determining the timing, position, and morphological
landmarks of the MD fusion:
Dissection at E13.5,
E14.5, and E15.5
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To validate the MD growth
and fusion model,
immunofluorescent staining
with markers for various
cellular processes such as
proliferation, apoptosis,
shape change, fate change,
and migration will need to be
performed.
Single cell transcriptome
analysis will be performed
on the determined ROI to
shed light on the underlying
molecular mechanism of MD
fusion.

Figure 4: The identified ROI
for single cell transcriptome
analysis.
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